Archived Grant Opportunity View - GO4450

The objective of this grant opportunity is to provide grants of financial assistance to support Australian medical research projects that conduct clinical trials to address one of the following topics:

• safer and more efficient ways to use high-cost medicines for one or more specific indications without compromising effectiveness. Priority areas include biological agents and other high-cost medicines
• other therapeutic indications for existing medicines that are not currently approved by the TGA. Priority areas include off-patent and other low-cost medicines.

Priority will be given to clinical trials investigating changes in the use of medicines that have the greatest potential impact on patients, clinical care and/or health service delivery.

This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health. 

Further information on the Medical Research Future Fund is available from the Department of Health website.

Applications will only be accepted from NHMRC approved Administering Institutions. A list of NHMRC approved Administering Institutions is available from the GrantConnect GO Documents and from the NHMRC’s Administering Institutions list on the NHMRC website.

Applications must satisfy all the requirements set out in the Medical Research Future Fund (MRFF) – Preventive and Public Health Research Initiative – 2020 Efficient Use of Existing Medicines Grant Opportunity Guidelines.

The maximum project period is 4 years

$7,500,000.00

Applicants are advised to read the Grant Guidelines thoroughly and liaise with the Administering Institution that will submit the application to identify any specific requirements that the Institution might have.

Applications must be submitted electronically using NHMRC’s online granting system (Sapphire)

Minimum Data closes at 5:00 pm (ACT Local Time) on 20 JAN 2021.

Questions should be submitted no later than 1:00 pm (ACT Local Time) on 27 JAN 2021.